Area at risk can be assessed by iodine-123-meta-iodobenzylguanidine single-photon emission computed tomography after myocardial infarction: a prospective study.
Hedon C, Huet F, Ben Bouallegue F, Vernhet H, Macia JC, Cung TT, Leclercq F, Cade S, Cransac F, Lattuca B, Vandenberghe D, Bourdon A, Benkiran M, Vauchot F, Gervasoni R, D'estanque E, Mariano-Goulart D, Roubille F.
Hedon C, et al. Among authors: ben bouallegue f.
Nucl Med Commun. 2018 Feb;39(2):118-124. doi: 10.1097/MNM.0000000000000782.
Nucl Med Commun. 2018.
PMID: 29194288
Clinical Trial.